Food and Drug Administration (FDA)

AlloSource Announces Milestone In Production Of Bioengineered Blood Vessels For Humacyte’s Vascular Access Phase III Clinical Trial

Centennial, Colo. – September 12, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures to advance patient healing, today announced a major milestone in its partnership with Humacyte. AlloSource completed production of investigational bioengineered blood vessels for Humacyte’s Phase III clinical trial. This Phase III clinical trial is investigating the potential of Humacyte’s HUMACYL® blood vessels to improve vascular access for hemodialysis patients with end-stage renal disease. The clinical trial compares the efficacy of Humacyte’s bioengineered human-tissue vessels to the current standard of synthetic vessels manufactured from…

AlloSource Distributes First Bioengineered Blood Vessels For Humacyte Phase III Clinical Trial

Centennial, Colo. — May 23, 2016 — AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced the distribution of investigational bioengineered blood vessels for Humacyte’s Phase III clinical trials. The first shipment of vessels will be used in the upcoming Phase III clinical trial, which will investigate the potential of Humacyte’s blood vessels to improve vascular access for hemodialysis patients with end-stage renal disease. The clinical trial will compare the efficacy of Humacyte’s vessels to the current standard of care,…

AlloSource’s New Cartilage Repair Product, ProChondrix, Receives Patent

Centennial, Colo. — January 19, 2016 — AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, was awarded U.S. Patent Number 9,186,253, titled Cartilage mosaic compositions and methods, for its new cartilage repair allograft, ProChondrix® Cartilage Restoration Matrix. ProChondrix is a cellular 3D fresh cartilage matrix that helps deliver the necessary components for cartilage restoration. This next generation of cartilage therapy provides live functional cells and other biological components necessary for repair and regeneration of damaged cartilage tissues. “With thousands of cartilage…